IM Cannabis Corp. (IMCC)

0.8897 -0.0203 (-2.23%) At close: 04:00PM EDT

IM Cannabis Corp.

Kibbutz Glil Yam
Central District
Tel Aviv 4690500
Israel

https://imcannabis.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 95

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Marc Lustig M.B.A., M.Sc.	Executive Chairman	95.01k	N/A	1974
Mr. Oren Shuster	CEO & Director	348.3k	N/A	N/A
Mr. Uri Birenberg	Chief Financial Officer	238.2k	N/A	1976
Mr. Richard Balla	Chief Executive Officer of Adjupharm	214.99k	N/A	N/A
Advocate Michal Lebovitz Nissimov	General Counsel	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.

Corporate governance

IM Cannabis Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.